If you experience severe or persistent symptoms, difficulty keeping fluids down, chest pain, shortness of breath, swelling of the face or throat, or any other concerning reactions, stop using the medication and seek medical attention promptly
SURPASS-CVOT is a phase 3 study enrolled approximately 13,000 patients at least 40 years of age and have a diagnosis of type 2 diabetes, confirmed atherosclerotic cardiovascular disease, HbA1c 7.0% to 10.5% and a body mass index (BMI) 25 kilograms per meter squared (kg/m 2 )
The content is editorially independent and is intended to provide helpful and accurate information to readers
Christopher McGowan told FOX Business that there is a "flourishing industry of unregulated, compounded versions of semaglutide that patients may not understand are vastly different than the brand-name, FDA-regulated drugs." Novo Nordisk said on Thursday that it is seeking to secure court orders to prevent these two compounding pharmacies from continuing their unlawful sales of adulterated and misbranded drugs claiming to contain semaglutide